Droplet Microfluidic and Magnetic Particles Platform for Cancer Typing - LAAS - Laboratoire d'Analyse et d'Architecture des Systèmes Accéder directement au contenu
Chapitre D'ouvrage Année : 2017

Droplet Microfluidic and Magnetic Particles Platform for Cancer Typing

Résumé

Analyses of nucleic acids are routinely performed in hospital laboratories to detect gene alterations for cancer diagnosis and treatment decision. Among the different possible investigations, mRNA analysis provides information on abnormal levels of genes expression. Standard laboratory methods are still not adapted to the isolation and quantitation of low mRNA amounts and new techniques needs to be developed in particular for rare subsets analysis. By reducing the volume involved, time process, and the contamination risks, droplet microfluidics provide numerous advantages to perform analysis down to the single cell level. We report on a droplet microfluidic platform based on the manipulation of magnetic particles that allows the clinical analysis of tumor tissues. In particular, it allows the extraction of mRNA from the total-RNA sample, Reverse Transcription, and cDNA amplification, all in droplets.
Fichier non déposé

Dates et versions

hal-02309980 , version 1 (09-10-2019)

Identifiants

Citer

Davide Ferraro, Jérôme Champ, Bruno Teste, M. Serra, Laurent Malaquin, et al.. Droplet Microfluidic and Magnetic Particles Platform for Cancer Typing. Microchip Diagnostics, pp.113-121, 2017, 978-1-4939-6732-2. ⟨10.1007/978-1-4939-6734-6_9⟩. ⟨hal-02309980⟩
36 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More